ArticleNeurochemical research2026
Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Alleviate Age-Related Insomnia in Rats by Suppressing Neuronal Ferroptosis in the Hippocampal Dentate Gyrus.
Article in Neurochemical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Age-related insomnia (ARI) is becoming increasingly prevalent among the elderly and remains inadequately addressed by conventional pharmacotherapy, prompting growing interest in stem cell-based alternatives. The present study investigated whether exosomes derived from umbilical cord mesenchymal stem cells (UCMSC-Exos) ameliorate ARI by suppressing hippocampal neuronal ferroptosis. UCMSCs were isolated from Sprague-Dawley rats on gestational day 21, and UCMSC-Exos were purified from passage 3 supernatants by ultracentrifugation. Transmission electron microscopy, nanoparticle tracking analysis, and western blotting confirmed characteristic exosomal morphology with a mean diameter of 118.4 nm, positive expression of TSG101, CD9, and CD81, and absence of Calnexin. Following tail vein injection of DiD-labeled UCMSC-Exos in rats, DiD signals were traceable for 21 days. An ARI model was established in adult male rats using D-galactose combined with para-chlorophenylalanine, and animals were randomized into Sham, ARI, ARI-UCMSC-Exos, and ARI-Fer-1 groups. Morris water maze, elevated plus maze, open field tests, and electroencephalography demonstrated that UCMSC-Exos reversed behavioral deficits and prolonged total and slow-wave sleep. Hematoxylin-eosin, Nissl, and Golgi staining revealed restored dentate gyrus neurons with increased dendritic number and length, while transmission electron microscopy showed improved synaptic and mitochondrial ultrastructure. Prussian blue staining, ELISA, and western blotting further indicated that UCMSC-Exos reduced Fe
Indexed as
Identifiers
42663757What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.